The Effectiveness of RECIST on Survival in Patients with NSCLC Receiving Chemotherapy with or without Target Agents as First-Line Treatment

We analyzed the correlation between survival and antitumor effect evaluated by RECIST in advanced NSCLC patients with chemotherapy plus target therapy or not as first-line treatment, to examine the applicability of RECIST in this population. The patients were screened from 4 clinical trials (12621,...

Description complète

Détails bibliographiques
Auteurs principaux: Zhou, Ting, Zheng, Lie, Hu, Zhihuang, Zhang, Yang, Fang, Wenfeng, Zhao, Yuanyuan, Ge, Jieying, Zhao, Hongyun, Zhang, Li
Format: Online Article Texte
Langue:English
Publié: Nature Publishing Group 2015
Sujets:
Article
Accès en ligne:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4286759/
https://www.ncbi.nlm.nih.gov/pubmed/25567662
http://dx.doi.org/10.1038/srep07683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4286759/
https://www.ncbi.nlm.nih.gov/pubmed/25567662
http://dx.doi.org/10.1038/srep07683

Documents similaires